Sign in
XBIOW Stock Price, Chart, Stats & News
Xenetic Biosciences, Inc.
Save
5.62M
Market cap
–
Current P/E
–
Forward P/E
XBIOW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | -95.23% |
Pretax margin | -90.07% |
Net margin | -90.07% |
Effective tax rate | – |
ROA | -32.05% |
ROE | -51.25% |
D/E | – |
Interest coverage ratio | – |
XBIOW valuation
P/E | – |
P/S | 1.56x |
P/B | 0.84x |
P/CF | -2.73x |
P/FCF | -2.02x |
P/OCF | -2.73x |
PEG | -0.11x |
EV multiple | -4.45x |
About
Xenetic Biosciences, Inc. is a biopharmaceutical enterprise primarily engaged in advancing XCART, a bespoke chimeric antigen receptor T cell (CAR T) platform technology. This innovative system is engineered to specifically target unique tumor neoantigens found in individual patients. The company's broader efforts encompass the creation of various biologic therapeutics and drugs.
Similar securities
Based on sector and market capitalization
Report issue